These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 29131875)
1. Association of LRRK2 Haplotype With Age at Onset in Parkinson Disease. Xiao B; Deng X; Ng EY; Allen JC; Lim SY; Ahmad-Annuar A; Tan EK JAMA Neurol; 2018 Jan; 75(1):127-128. PubMed ID: 29131875 [TBL] [Abstract][Full Text] [Related]
2. LRRK2 and the new era of Parkinson's disease research. The Lancet Neurology Lancet Neurol; 2016 Nov; 15(12):1195. PubMed ID: 27751534 [No Abstract] [Full Text] [Related]
3. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822 [TBL] [Abstract][Full Text] [Related]
4. α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain. Fernández-Santiago R; Garrido A; Infante J; González-Aramburu I; Sierra M; Fernández M; Valldeoriola F; Muñoz E; Compta Y; Martí MJ; Ríos J; Tolosa E; Ezquerra M; Mov Disord; 2018 Apr; 33(4):637-641. PubMed ID: 29473656 [TBL] [Abstract][Full Text] [Related]
5. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901 [TBL] [Abstract][Full Text] [Related]
6. Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease. Correia Guedes L; Reimão S; Paulino P; Nunes RG; Bouça-Machado R; Abreu D; Gonçalves N; Soares T; Fabbri M; Godinho C; Pita Lobo P; Neutel D; Quadri M; Coelho M; Rosa MM; Campos J; Outeiro TF; Sampaio C; Bonifati V; Ferreira JJ Mov Disord; 2017 Sep; 32(9):1331-1333. PubMed ID: 28686310 [No Abstract] [Full Text] [Related]
12. Increased substantia nigra echogenicity in LRRK2 family members without mutations. Pullman M; Ortega R; Glickman A; Deik A; Raymond D; Marder K; Giladi N; Bressman S; Hagenah J; Brüggemann N; Saunders-Pullman R Mov Disord; 2018 Sep; 33(9):1504-1505. PubMed ID: 30145825 [No Abstract] [Full Text] [Related]
13. Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson's disease nonparkinsonian relatives: A multicenter family study. Mestre TA; Pont-Sunyer C; Kausar F; Visanji NP; Ghate T; Connolly BS; Gasca-Salas C; Kern DS; Jain J; Slow EJ; Faust-Socher A; Kasten M; Wadia PM; Zadikoff C; Kumar P; de Bie RM; Thomsen T; Lang AE; Schüle B; Klein C; Tolosa E; Marras C Mov Disord; 2018 Jul; 33(6):960-965. PubMed ID: 29665080 [TBL] [Abstract][Full Text] [Related]
14. LARGE-PD: Examining the genetics of Parkinson's disease in Latin America. Zabetian CP; Mata IF; Mov Disord; 2017 Sep; 32(9):1330-1331. PubMed ID: 28657124 [No Abstract] [Full Text] [Related]
15. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease. Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063 [TBL] [Abstract][Full Text] [Related]
16. Association of LRRK2 and GBA mutations in a Brazilian family with Parkinson's disease. Spitz M; Pereira JS; Nicareta DH; Abreu Gde M; Bastos EF; Seixas TL; Pimentel MM Parkinsonism Relat Disord; 2015 Jul; 21(7):825-6. PubMed ID: 25952961 [No Abstract] [Full Text] [Related]
17. A novel rare variant of LRRK2 associated with familial Parkinson's disease: p.R1501W. Masuzugawa S; Nishioka K; Imai Y; Ogata J; Shojima Y; Li Y; Yoshino H; Hattori N Parkinsonism Relat Disord; 2020 Jul; 76():46-48. PubMed ID: 32563051 [No Abstract] [Full Text] [Related]
18. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect? Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369 [TBL] [Abstract][Full Text] [Related]